Listen to Gynecologic Oncology
By Gynecologic Oncology
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Gynecologic Oncology
Category: Science
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 5
Reviews: 0
Episodes: 51
Description
Listen to the latest news from the experts in your field.
| Episode | Date |
|---|---|
|
Prophylactic chemotherapy to prevent post-molar gestational trophoblastic disease - a long journey and a remarkable study
|
Mar 03, 2025 |
|
Clinical trials: Panacea or pitfall
|
Jan 27, 2025 |
|
FOLR1 status: Landscape beyond high grade serous ovarian cancer
|
Dec 30, 2024 |
|
Benefits of hormonal therapy for low grade serous ovarian cancer
|
Dec 30, 2024 |
|
Implementation and impact of a financial navigation program in gynecologic oncology
|
Oct 23, 2024 |
|
LVSI in Stage 1 Endometrial Cancer
|
Sep 25, 2024 |
|
Primary Surgery versus Radiotherapy for Inguinal Lymph Nodes in Vulvar Cancer
|
Sep 02, 2024 |
|
Shifting trends and sicker patients - the future of gynecologic cancer
|
Jul 12, 2024 |
|
2023 FIGO staging for endometrial cancer: a reappraisal on the path to continuous improvement
|
Jul 08, 2024 |
|
Editor's Choice: SENTIREC-endo study: Is the juice worth the squeeze?
|
Apr 15, 2024 |
|
Editor's Choice: Caring for the Caregiver
|
Apr 04, 2024 |
|
Editor’s Choice: Engagement with ERAS patients leads to improved outcomes
|
Jan 29, 2024 |
|
October 2023 Editor’s Choice: OS updates for Imagyn50
|
Nov 17, 2023 |
|
September 2023 Editor’s Choice: Is now the time to begin thromboprophylaxis for all patients with advanced ovarian cancer, including those undergoing neoadjuvant chemotherapy?
|
Oct 27, 2023 |
|
August 2023 Editor’s Choice: What is your center doing to improve genetic testing following abnormal MMR results in endometrial cancer?
|
Sep 28, 2023 |
|
July 2023 Editor’s Choice: The evolution of patient-centered endometrial cancer detection: testing tompon-based collection for methylated DNA markers
|
Aug 16, 2023 |
|
TKI Toxicities: A Society of Gynecologic Oncology Podcast
|
Jul 10, 2023 |
|
June 2023 Editor's Choice: ERAS Society Updates: What Every Gyn Oncologist Should Know
|
Jul 01, 2023 |
|
April 2023 Editor’s Choice: The times they are a changin’ – the future of the specialty
|
May 12, 2023 |
|
March 2023 Editor’s Choice: Intrathoracic Surgery and Ovarian Cancer Cytoreduction: Why the Chest Matters
|
Apr 11, 2023 |
|
February 2023 Editor’s Choice: A Geo-Analyzer Tool that assessed insured patients in your metropolitan area with recurrent and metastatic cervix cancer
|
Feb 02, 2023 |
|
Burnout and gynecologic oncology - does the problem still exist?
|
Jan 05, 2023 |
|
January 2023 Editor’s Choice: Sentinel lymph node mapping in endometrial complex atypical hyperplasia: good idea or have we gone too far?
|
Jan 05, 2023 |
|
Molecular Testing for Endometrial Cancer: A Society of Gynecologic Oncology Podcast
|
Jan 05, 2023 |
|
December 2022 Editor’s Choice: Exceptional PARP inhibitor responders: the good and the bad
|
Dec 29, 2022 |
|
November 2022 Editor’s Choice: Management of primary low-grade serous ovarian carcinoma: are you up-to-date on the most contemporary prognostic factors and treatment strategies?
|
Nov 03, 2022 |
|
October 2022 Editor’s Choice: How do you manage the contralateral groin in early stage vulvar cancer with a unilateral positive sentinel lymph node?
|
Oct 06, 2022 |
|
September 2022 Editor’s Choice: Frailty assessment in gynecologic oncology - have you incorporated this into your practice?
|
Sep 08, 2022 |
|
July 2022 Editor’s Choice: Complications after cytoreductive surgery and its impact on survival: where do we go from here?
|
Jul 07, 2022 |
|
Immunotherapy Toxicities: A Society of Gynecologic Oncology Podcast
|
Jun 09, 2022 |
|
June 2022 Editor’s Choice: Long-term cardiovascular complications among gynecologic cancer survivors
|
Jun 09, 2022 |
|
April 2022 Editor’s Choice: Reducing non-surgical readmissions in gynecologic oncology
|
Apr 07, 2022 |
|
March 2022 Editor’s Choice: Improving QOL for patients with cervical cancer: SLN biopsy
|
Mar 03, 2022 |
|
February 2022 Editor’s Choice: HRD: What does it really mean and are we looking at this the right way?
|
Feb 03, 2022 |
|
January 2022 Editor’s Choice: Optimizing Rural Ovarian Cancer Care
|
Jan 06, 2022 |
|
December 2021: Recurrent Endometrial Cancer: A Society of Gynecologic Oncology Podcast
|
Dec 09, 2021 |
|
Looking Back at 2021: November Editor’s Choice
|
Nov 04, 2021 |
|
April 2021: Differences in cervical cancer screening and follow-up for black and white women in the United States
|
Apr 08, 2021 |
|
March 2021: The Future Of Gynecologic Oncology: We are at a Crossroads
|
Mar 04, 2021 |
|
April 2020: 2020 Rare Tumors and Conditions
|
Oct 08, 2020 |
|
August 2020: 2020 Virtual Annual SGO Meeting Report
|
Aug 12, 2020 |
|
PARP Inhibitor Maintenance Therapy after Initial Chemotherapy for Advanced Ovary, Fallopian Tube and Primary Peritoneal Cancers
|
May 23, 2020 |
|
Special Topics: Present and Future Impact of COVID-19 on the Practice and Delivery on Gynecologic Oncology Care
|
Mar 26, 2020 |
|
February 2020 Editor's Choice: Financial hardship among gynecologic cancer patients
|
Feb 26, 2020 |
|
January 2020 Editor’s Choice - Does the transcriptome of ovarian neoplasms provide insight into its potential behavior?
|
Jan 30, 2020 |
|
December 2019 Editor's Choice
|
Dec 24, 2019 |
|
November 2019 Editor’s Choice - Survival of endometrial cancer patients following lymphadenectomy or sentinel node procedure
|
Nov 30, 2019 |
|
Inaugural Gynecologic Oncology Podcast - When to stop hCG surveillance following chemotherapy for gastational trophoblastic neoplasia
|
Nov 04, 2019 |
|
Understanding the Implications of the Platinum-Free Interval in Endometrial Cancer
|
Jan 01, 1970 |
|
Editor’s Choice: Lunchbox Trial
|
Jan 01, 1970 |
|
May 2023 Editor's Choice: Prioritizing and achieving diversity in clinical trial enrollment
|
Jan 01, 1970 |